|
|
|
| Clinical application analysis of intra-aortic balloon counterpulsation in the treatment of acute coronary syndrome |
| DENG Shi-lei PENG Zhi-bin YANG Ze-min LI Bo-hua |
| Department of Internal Medicine-Cardiovascular,the First People′s Hospital of Yidu City in Hubei Province,Yidu 443300,China |
|
|
|
|
Abstract ObjectiveTo analyze the clinical value of intra-aortic balloon counterpulsation in the treatment of acute coronary syndrome.MethodsA total of 60 patients with acute coronary syndromes were enrolled in our hospital from 2010 to 2016.According to the principle of patient autonomy(taking into account the economic status and physical condition),the patients were divided into the observation group and the control group,30 cases in each group.The observation group was given intra-aortic balloon counterpulsation,the control group was given conventional treatment.The clinical effects of the two groups were compared.ResultsCompared with before treatment,the systolic and diastolic blood pressure of the two groups after treatment were significantly improved,with significant difference (P＜0.05).After treatment,the systolic blood pressure and diastolic blood pressure were significantly increased,compared with the control group,there was statistically significant(P＜0.05).The frequency of angina pectoris,the longest duration and the amount of nitroglycerin after treatment were significantly improved in the two groups,compared with before treatment,there was statistically significant(P＜0.05).After treatment,the frequency of angina pectoris and the longest duration of angina pectoris in the observation group were better than those in the control group after treatment,and the difference was statistically significant(P＜0.05).Compared with before treatment,the cardiac function LVEF and BNP were improved in the two groups after treatment,the difference was statistically significant(P＜0.05),especially in the observation group,the difference was statistically significant(P＜0.05).The incidence of adverse reactions,the average hospitalization,and the mortality rate in the observation group were significantly better than those in the control group,with significant difference (P＜0.05).ConclusionIntra-aortic balloon counterpulsation in the treatment of acute coronary syndrome can effectively improve the cardiac function of patients with acute coronary syndrome,it is worth promoting.
|
|
|
|
|
|
| [4] |
朱洁莹，刘丽军，信栓力，等.主动脉内球囊反搏术治疗急性冠脉综合征伴心源性休克的应用[J].心血管康复医学杂志，2013，22（5）：497-499.
|
| [5] |
胡蓉芳，杨重明，普顺华，等.主动脉内球囊反搏在急性冠脉综合征患者中的临床应用[J].云南医药，2012，33（2）：143.
|
| [6] |
何天民.主动脉内球囊反搏治疗心肌梗死合并心源性 休克的价值探讨[J].中国当代医药，2014，21（32）：185，189.
|
| [1] |
Walkowicz W，Gasior Z，Mizia-Stec K，et al.Risk factors of death or re-hospitalization in acute coronary syndrome patients before and after earlier heart revascularization[J].Pol Merkur Lekarski，2011，30（176）：97-101.
|
| [2] |
汪砚雨，段洪强，董平栓，等.主动脉内球囊反搏在急性心肌梗死合并心源性休克的老年患者冠状动脉介入术中的疗效和安全性评价[J].中国全科医学，2011，14（20）：2257-2259.
|
| [3] |
彭晓鹏，朱洪玉，林明，等.主动脉内球囊反搏联合小剂量呋塞米治疗重症心脏瓣膜病患者术后并发低心排综合征的效果分析[J].中国当代医药，2016，23（19）：40-43.
|
| [7] |
杨芳，卢静，赖碁，等.主动脉内球囊反搏在急性冠脉综合征中的临床应用观察[J].昆明医学院学报，2011，32（9）：80-82.
|
| [8] |
马福义，莫海亮，蔡玉洁.45例接受IABP治疗的高危急性冠脉综合征患者的并发症分析[J].医学理论与实践，2014，27（17）：2276-2278.
|
| [9] |
张鹏飞，钟志雄，李斌，等.主动脉内球囊反搏在急性冠脉综合征的应用效果观察[J].当代医学，2013，19（22）：47-48.
|
| [10] |
李红，贾若飞，孟帅，等.主动脉内球囊反搏辅助经皮冠状动脉介入治疗急性冠状动脉综合征合并心源性休克患者的特征及预后分析[J].中国介入心脏病学杂志，2017，3（25）：121-126.
|
| [11] |
杨辉，肖平喜，程久佩，等.385例高危急性冠脉综合征患者的 IABP相关并发症分析 [J].中国医学创新，2012，9（33）：125-126.
|
| [12] |
崔锦钢，吴元，赵冬云，等.主动脉内球囊反搏在急性冠状动脉综合征治疗中的临床应用及并发症情况分析[J].中国循环杂志，2015，30（2）：107-110.
|
| [13] |
Quinones A，Saric M.The cholesterol emboli syndrome in atherosclerosis[J].Curr Atheroscler Rep，2013，15（4）：315.
|
| [14] |
刘丽，杨婷，潘宏伟，等.主动脉内球囊反搏在急性冠脉综合征患者中的临床应用[J].湖南师范大学学报（医学版），2012，9（1）：40-44.
|
| [15] |
Vales L，Kanei Y，Ephrem G，et al.Intra-aortic balloon pump use and outcomes with current therapy[J].J Invasive Cardiol，2011，23（3）：116-119.
|
|
|
|
